GlassScriptPhysician profile
Sean K Park
NPI 1164081782
$2,947.03
in general payments reported to CMS, 2019-2025
14 companies · $2,105 in 2025
The $2,105 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $16.92 · 2022: $150 · 2023: $112 · 2024: $442 · 2025: $2,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Travel and Lodging: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.24 |
| Travel and Lodging | $1,069.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,353.24 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $283.08 | 2025 | |
| Polynovo North America LLC | $219.39 | 2024-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $169.10 | 2025 | Cohealyx, Permeaderm, Recell |
| Allergan, INC. | $149.90 | 2022 | |
| Zimmer Biomet Holdings, INC. | $146.68 | 2024 | Dvr Anatomic Kickstand |
| Mallinckrodt Enterprises LLC | $121.08 | 2019 | |
| Solventum Corporation | $114.92 | 2025 | Prevena Restor Bellaform, Prevena, V.A.C. Veraflo Cleanse Choice |
| Heron Therapeutics, INC. | $112.14 | 2023 | Zynrelef |
| Kerecis Limited | $95.02 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Motiva USA, LLC | $65.23 | 2025 | |
| Revance Therapeutics, INC. | $57.85 | 2025 | Daxxify |
| Abiomed | $42.48 | 2024 | Impella |
| Convatec INC. | $16.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.